Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Enthusiasm Builds For Biogen’s BAN2401 In Alzheimer's, But SMA Gene Therapy Hits A Snag

Jul 24 2018

• By Jessica Merrill

magnetic resonance image (MRI) of the brain human

Related Content

Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisition

Apr 09 2018

Biogen's Spinraza Sales Plateau; The Challenge Is Keeping Up With The Successful Launch

Apr 24 2018

Biogen Re-Ups With Ionis In Search Of A Neuroscience 'Innovation Engine'

Apr 20 2018

BAN2401 Results Validate Eisai/Biogen's Faith In Alzheimer's Amyloid Tack

Jul 06 2018

Related Companies

Biogen, Inc.

Eisai Co., Ltd.

Novartis AG

TMS Co., Ltd.

Ionis Pharmaceuticals, Inc.

Additional Topics

Sales & Earnings Clinical Trials Drug Approval Standards Commercial Neurology BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.